Status:
COMPLETED
Efficacy and Safety of an H.Pylori Vaccine in H.Pylori-Negative Adults
Lead Sponsor:
Novartis Vaccines
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
18-40 years
Phase:
PHASE1
Brief Summary
To study the safety, immunogenicity and efficacy of an investigational H. pylori vaccine, compared with placebo.
Eligibility Criteria
Inclusion
- adults 18 - 40 years of age in good health
- HP uninfected
- not pregnant and agree to use birth control throughout the study (females who can become pregnant)
Exclusion
- remote or current HP infection
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT00736476
Start Date
October 1 2008
End Date
April 1 2010
Last Update
February 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Otto von Guericke Universität Magdeburg
Magdeburg, Germany, 39120